TP53 and cancer: TP53 mRNA expression was significantly higher in samples with missense and in-frame mutations, while samples with nonsense, frameshift, and splice site mutations had significantly lower TP53 expression than cancer-adjacent normal breast tissue samples (Fig. 2b).